Member Login
  1. Stocks
    2. /
  2. BELLUS Health Inc. (TSX: BLU)
    3. /

TSX:BLU (BELLUS Health Inc.)

About BLU

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • BELLUS Health Inc. (TSX: BLU) Latest News

    Workers use a microscope to do medical research in a modern laboratory.
    Tech Stocks

    These Canadian Biotech Stocks Are Quietly Changing the Face of Healthcare

    | Ambrose O'Callaghan

    Canadians on the hunt for growth should look to exciting biotech stocks like Fennec Pharmaceuticals Inc. (TSX:FRX) and others.

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Tech Stocks

    These Canadian Biotech Stocks Are Quietly Changing the Face of Healthcare

    | Brian Paradza, CFA

    Canadian biotech stock BELLUS Health has been snatched from the public market. However, these two biopharma growth stocks also have…

    Read more »

    Coronavirus

    TSX Stocks in the Healthcare Industry: Which Ones Are Worth Your Money?

    | Amy Legate-Wolfe

    These healthcare stocks all offer different investment opportunities for investors, but which are the best buys on the TSX today?

    Read more »

    tsx today
    Stocks for Beginners

    TSX Today: What to Watch for in Stocks on Monday, April 24

    | Jitendra Parashar

    TSX investors will remain focused on corporate earnings this week.

    Read more »

    tsx today
    Stocks for Beginners

    TSX Today: Why Canadian Stocks Could Fall on Wednesday, April 19

    | Jitendra Parashar

    Steep intraday losses in commodity prices could pressurize the main TSX index at the open today.

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Investing

    4 Biotech Stocks That Could Break Through the Market

    | Christopher Liew, CFA

    Four TSX biotech stocks could deliver outsized gains in 2023, as they are poised to break through the market soon.

    Read more »

    Investing

    2022’s Top Small Caps on the TSX: Are They Buys Today?

    | Daniel Da Costa

    These top small-caps were some of the few gainers on the TSX in 2022. But are these stocks worth buying…

    Read more »

    lab worker inspects test tubes
    Dividend Stocks

    3 Biotech Stocks to Buy Before the Down Market Is Over

    | Christopher Liew, CFA

    Biotech stocks are high-risk, high-reward investments, although three names are buying opportunities in the current down market.

    Read more »

    Investing

    2 Biotech Stocks to Buy Before the Down Market Recovers

    | Adam Othman

    While not all biotech stocks are trading at a discount, a holistic recovery is likely to push their prices higher.

    Read more »

    Dividend Stocks

    3 Growth Stocks You Can Buy Right Now with Less Than $100

    | Christopher Liew, CFA

    Capital of less than $100 is enough to buy one of these three promising growth stocks that don't belong to…

    Read more »

    Investing

    2 Best Healthcare Stocks to Buy Right Now

    | Brian Paradza, CFA

    BELLUS Health (TSX:BLU) is a Canadian biotech stock with promise. Income investors seeking juicy yields from healthcare stocks may look…

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Investing

    2 Top Healthcare Stocks Defying the Bear Market

    | Vishesh Raisinghani

    Healthcare stocks like Bellus Health (TSX:BLU) are defying the bear market.

    Read more »